Clinical trial
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
NCT00051545 · LEO Pharma, Industry · Terminated
Key facts
| NCT number | NCT00051545 |
|---|---|
| Title | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma |
| Official title | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5 ug) or Placebo in Prolonging Time to Relapse Following Intended Curative Resection or Percutaneous Ablative Treatment for Hepatocellular Carcinoma |
| Lead sponsor | LEO Pharma, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Neoplasms |
| Intervention type | Drug |
| Interventions | Seocalcitol |
| Enrollment | 608 |
| Start date | Nov 1, 1999 |
| Completion | Jun 1, 2004 |
| First posted | Jan 14, 2003 |
| Last update posted | Feb 25, 2025 |
| Countries | Canada, France, Italy, Spain, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: